Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application
30 December 2022 - 1:05AM
Business Wire
Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a
global medical technology company focused on delivering leading
edge silicon photonics-based biosensing solutions by targeting a
portfolio of biomarkers, today announced that it received 12.9
million pounds sterling ($15.5 million) for its fiscal 2020 R&D
tax credit from HMRC, the tax agency of the UK government. The
Company filed its fiscal 2021 R&D tax credit application and
expects to file its fiscal 2022 R&D tax credit application in
2023.
About Rockley Photonics
Formed in 2013, Rockley is a global medical technology company
focused on delivering leading edge silicon photonics-based
biosensing solutions that target a portfolio of biomarkers.
Rockley's ground-breaking end-to-end biosensing platform unlocks
unique spectra-based biomarkers enabling insights into personal
health and well-being. With next-generation biosensing platforms
specifically designed for mobile health monitoring, Rockley is
laying the foundation for a new generation of biomedical
applications across multiple industries.
To learn more about Rockley, visit rockleyphotonics.com.
Cautionary Note Regarding Forward-Looking Statements
Statements in this press release that are not historical facts
constitute “forward-looking statements” for purposes of the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements include statements
regarding Rockley’s future expectations, beliefs, plans,
objectives, and assumptions regarding future events or performance.
The words “accelerate,” “advance,” “anticipate,” “believe,” “can,”
“capability,” “continue,” “could,” “develop,” “enable,” “enhance”,
“estimate,” “eventual,” “expand, “expect,” “focus,” “forward,”
“future,” “goal,” “ground-breaking” “intend,” “may,” “might,”
“opportunity,” “outlook,” “plan,” “possible,” “position,”
“potential,” “predict,” “project,” “revolutionize,” “seem,”
“should,” “trend,” “vision,” “will,” “would” or other terms that
predict or indicate future events, trends, or expectations, and
similar expressions or the negative of such expressions may
identify forward-looking statements, but the absence of these words
or terms does not mean that a statement is not forward-looking.
Forward-looking statements in this press release include, but are
not limited to, statements regarding the following: (a) the timing
of tax grant applications and expected receipt of future tax
grants; and (b) our belief that we are laying the foundation for a
new generation of applications across multiple industries, and the
extent to which we may expand our focus beyond biosensing
solutions.
Forward-looking statements are subject to several risks,
assumptions, and uncertainties (many of which are beyond Rockley’s
control) that may cause actual results or performance to differ
materially from those expressed or implied by these forward-looking
statements. These risks, assumptions, and uncertainties include,
but are not limited to, the factors described under the heading
“Risk Factors” in our Annual Report on Form 10-K for the year ended
December 31, 2021, and in other documents we file with the
Securities and Exchange Commission. If any of these risks or
uncertainties materialize, or should any of these assumptions prove
incorrect, actual results may differ materially from those
discussed in or implied by these forward-looking statements. There
can be no assurance that future developments affecting Rockley will
be those that have been anticipated. Given these risks and
uncertainties, you should not place undue reliance on these
forward-looking statements. These forward-looking statements speak
only as of the date hereof and Rockley does not intend to update or
revise any forward-looking statements, whether because of new
information, future events, or otherwise, except as required by
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221229005044/en/
Contact Information Gwyn Lauber Rockley Photonics Telephone: +1
626-995-0001 Email: investors@rockleyphotonics.com
Rockley Photonics (NYSE:RKLY)
Historical Stock Chart
From Jan 2025 to Feb 2025
Rockley Photonics (NYSE:RKLY)
Historical Stock Chart
From Feb 2024 to Feb 2025